Log in to save to my catalogue

Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney...

Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ecc2738f9e3452ea995a1ea63c3031c

Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney disease patients

About this item

Full title

Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney disease patients

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-04, Vol.13 (1), p.6161-6161, Article 6161

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Chronic kidney disease (CKD) is a serious public health problem characterized by progressive kidney function loss leading to end-stage renal disease (ESRD) that demands dialysis or kidney transplantation. Early detection can prevent or delay progression to ESRD. The study aimed to gain new insights into the perturbed biochemical reactions and to id...

Alternative Titles

Full title

Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney disease patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9ecc2738f9e3452ea995a1ea63c3031c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ecc2738f9e3452ea995a1ea63c3031c

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-33377-8

How to access this item